Correlation Between Scopus Biopharma and Axcella Health
Can any of the company-specific risk be diversified away by investing in both Scopus Biopharma and Axcella Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scopus Biopharma and Axcella Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scopus Biopharma and Axcella Health, you can compare the effects of market volatilities on Scopus Biopharma and Axcella Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scopus Biopharma with a short position of Axcella Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scopus Biopharma and Axcella Health.
Diversification Opportunities for Scopus Biopharma and Axcella Health
0.56 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Scopus and Axcella is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Scopus Biopharma and Axcella Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Axcella Health and Scopus Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scopus Biopharma are associated (or correlated) with Axcella Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Axcella Health has no effect on the direction of Scopus Biopharma i.e., Scopus Biopharma and Axcella Health go up and down completely randomly.
Pair Corralation between Scopus Biopharma and Axcella Health
If you would invest 20.00 in Axcella Health on September 1, 2024 and sell it today you would earn a total of 0.00 from holding Axcella Health or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Scopus Biopharma vs. Axcella Health
Performance |
| Timeline |
| Scopus Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Axcella Health |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Scopus Biopharma and Axcella Health Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scopus Biopharma and Axcella Health
The main advantage of trading using opposite Scopus Biopharma and Axcella Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scopus Biopharma position performs unexpectedly, Axcella Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axcella Health will offset losses from the drop in Axcella Health's long position.| Scopus Biopharma vs. Scpharmaceuticals | Scopus Biopharma vs. DiaMedica Therapeutics | Scopus Biopharma vs. Monopar Therapeutics | Scopus Biopharma vs. Pasithea Therapeutics Corp |
| Axcella Health vs. Cyclerion Therapeutics | Axcella Health vs. Kezar Life Sciences | Axcella Health vs. CytomX Therapeutics | Axcella Health vs. Assembly Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |